Cell therapy in solid organ transplantation
S Cai, A Chandraker - Current Gene Therapy, 2019 - ingentaconnect.com
Transplantation is the only cure for end-stage organ failure. Current immunosuppressive
drugs have two major limitations: 1) non antigen specificity, which increases the risk of …
drugs have two major limitations: 1) non antigen specificity, which increases the risk of …
[引用][C] Cell Therapy in Solid Organ Transplantation
S Cai, A Chandraker - Current Gene Therapy, 2019 - ingentaconnect.com
Graphical Abstracts Page 1 Graphical Abstracts Current Gene Therapy, 2019, Vol. 19, No. 2 i
Graphical Abstracts Current Gene Therapy, 2019, Vol. 19, No. 2 71 Cell Therapy in Solid …
Graphical Abstracts Current Gene Therapy, 2019, Vol. 19, No. 2 71 Cell Therapy in Solid …
Cell Therapy in Solid Organ Transplantation.
S Cai, A Chandraker - Current Gene Therapy, 2019 - europepmc.org
Transplantation is the only cure for end-stage organ failure. Current immunosuppressive
drugs have two major limitations: 1) non antigen specificity, which increases the risk of …
drugs have two major limitations: 1) non antigen specificity, which increases the risk of …
Cell Therapy in Solid Organ Transplantation
S Cai, A Chandraker - Current gene therapy, 2019 - pubmed.ncbi.nlm.nih.gov
Transplantation is the only cure for end-stage organ failure. Current immunosuppressive
drugs have two major limitations: 1) non antigen specificity, which increases the risk of …
drugs have two major limitations: 1) non antigen specificity, which increases the risk of …